Announcement on Voluntary Disclosure of Obtaining Drug Clinical Trial Approval Notice for the Combination of ZG006 for Injection with Etoposide and Cisplatin

About this update from Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Drug Clinical Trial Approval Notice for the Combination of ZG006 for Injection with Etoposide and CisplatinThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A